Metastatic Breast Cancer

Paolo Tarantino, MD, speaks with Healio about future research directions in metastatic breast cancer.

Paolo Tarantino, MD, highlights modifiable risk factors for metastatic breast cancer.

Healio spoke with Paolo Tarantino, MD, about treatments in the pipeline for metastatic breast cancer.

Healio spoke with Paolo Tarantino, MD, about FDA approvals in metastatic breast cancer.

Compared with standard-of-care chemotherapy, trastuzumab deruxtecan demonstrated a statistically significant improvement in PFS among certain patients with metastatic breast cancer, according to a press release from the manufacturer.

Daily aspirin use did not reduce disease recurrence, progression or mortality in patients with high-risk breast cancer, according to extended follow-up results of a terminated study published in JAMA.

SAN ANTONIO — Futibatinib plus fulvestrant exhibited antitumor activity among certain patients with locally advanced or metastatic breast cancer with fibroblast growth factor receptor 1 amplification, according to study results.

The treatment landscape for metastatic breast cancer has evolved tremendously within the past 2 decades.

SAN ANTONIO — A four-therapy combination conferred clinical benefit to nearly all evaluable patients with metastatic triple-positive breast cancer, according to findings of the ASPIRE trial presented at San Antonio Breast Cancer Symposium.

SAN ANTONIO — Patients with metastatic breast cancer who take part in a supervised, structured exercise program during palliative treatment may experience improved quality of life, according to study results.